… vaccination rates remain low. The FDA approved epinephrine nasal spray (neffy; ARS Pharmaceuticals … phase 3 trials, the treatment significantly improved … CLEVER trial, clesrovimab reduced medically attended … biosimilar to ustekinumab (Stelara), in a 45mg …

… treatments without medication side effects. On June 9, 2025, the FDA … phase 3 SMART trials, which demonstrated that … a biosimilar to ustekinumab (Stelara), in a 45mg… sebetralstat (KalVista Pharmaceuticals), an investigational oral treatment for hereditary …

… the eighth Stelara (ustekinumab, Janssen Biotech) biosimilar … FDA approved a supplemental new drug … treatment options were limited and often involved corticosteroids and immunosuppressants — medications … LTD, Novartis Pharmaceuticals Corp., Oruka Therapeutics …

… obtained the Food and Drug Administration’s clearance for … is approved for the treatment of pediatric patients aged … ; clinical needs while supporting treatment continuity for patients, Celltrion … Solutions, Hikma get FDA nod for generic Stelara] In December …

… monoclonal antibody referencing Stelara®. The CHMP… treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical … candidates in clinical trials, focusing on … uncertainties inherent in pharmaceutical research and development, …

… blockbuster medicines like Humira for rheumatoid arthritis, Keytruda for cancer treatment, Stelara for … Pharma, and Bharat Serums and Vaccines (now part of Mankind Pharma … benefit companies bringing in innovative medicines. Drugs like AstraZeneca's …

… . For example, Vertex Pharmaceutical’s cystic fibrosis medication Trikafta/Kaftrio is … generation cardiometabolic drugs, as well, for a chance at treatments that work … with two megablockbusters: its immunology drug Stelara and an oncology therapy Darzalex …

… , 2025, Celltrion announced that the FDA has approved a new 45mg … strengths of its reference product, STELARA, including 45mg/0.5mL … been granted full interchangeability with STELARA across all indications. [View source …

… biosimilar monoclonal antibody referencing Stelara.  The CHMP’s positive … to commercialize the medicine upon approval and … to Janssen’s Stelara which is a … treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical …

… and Drug Administration (FDA) seeking to expand approval of STELARA (ustekinumab) for the treatment … Gasink, M.D., Vice President, Medical Affairs, Gastroenterology & Autoantibody, Johnson …